Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4045/tidsskr.20.0603 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Theatre Safety Club 2024 took place on 6 November in London and on 26 November in Newcastle. The CPDcertified event aimed to educate and provide insight into safety in the operating theatre, boasting an impressive line-up of speakers and sessions that were well attended. The conference was sponsored by Cardinal Health, a leading healthcare company providing value-based product solutions, with a comprehensive portfolio covering mechanical thromboprophylaxis, nutritional insufficiency solutions, thermometry and surgical gloves.
View Article and Find Full Text PDFVariations in Perioperative Thromboprophylaxis Practices: Do the Guidelines Need a Closer Look?
Ann Thorac Surg Short Rep
September 2024
Division of Thoracic Surgery, Department of Surgery, Hackensack Meridian Health Network, Hackensack, New Jersey.
Background: In 2022, the American Association for Thoracic Surgery (AATS) and the European Society of Thoracic Surgeons (ESTS) published joint guidelines regarding the timing, duration, and choice of agent for perioperative venous thromboembolism prophylaxis for thoracic cancer patients. Now, 1 year after their release, we looked to assess practices and general adherence to these recommendations.
Methods: We conducted a survey among board-certified/board-eligible thoracic surgeons in the United States, between July and October 2023.
Thromboprophylaxis in patients with locally advanced cervical cancer treated with chemoradiation and brachytherapy.
Gynecol Oncol
January 2025
Department of Radiation-Oncology, Catharina Hospital, Eindhoven, the Netherlands.
Objective: To determine the incidence of clinical and subclinical venous thromboembolic events (VTE) in patients with locally advanced cervical cancer (LACC) treated with high-dose thromboprophylaxis during definitive chemoradiation and brachytherapy.
Methods: A prospective observational study was undertaken from August 2021 to December 2023 in patients with primary LACC treated with definitive chemoradiation in two Dutch tertiary hospitals. Patients received high-dose thromboprophylaxis during chemoradiation and brachytherapy.
The use of direct oral anticoagulants (DOACs) for thromboprophylaxis during neoadjuvant chemotherapy and after interval debulking surgery in ovarian cancer patients - Maximizing prevention of venous thromboembolism (VTE).
Gynecol Oncol Rep
December 2024
The University of Alabama at Birmingham, Division of Gynecologic Oncology, Birmingham, AL, United States.
Upper Limb Deep Venous Thrombosis Associated With Peripherally Inserted Central Catheters in Hospitalised Surgical Patients.
Cureus
December 2024
Cardiology, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, GBR.
Introduction Surgical inpatients frequently require peripherally inserted central catheters (PICCs) for parenteral feeding and administration of medication. PICCs may cause upper limb deep venous thrombosis (ULDVT), which impacts patient morbidity. We investigated the risk and prevention of PICC-ULDVT in hospitalised surgical inpatients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!